BioPharma Credit PLC (BPCR.L) LSE

Currency In USD

AD

Valuation

Market Cap1.04B
Enterprise Value1.03B
P/E Ratio8.6
PEG Ratio0.83
Price/Sales Ratio7.84
Price/Book Ratio0.97
Enterprise/Revenue7.35
Enterprise/EBITDA7.94

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.93
Operating Margin0.93
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.11

Income Statement

Revenue140.23M
Revenue/Share0.12
Gross Profit114.5M
EBITDA129.89M
Net Income129.89M
Diluted EPS0.11

Balance Sheet

Total Cash68.71M
Total Cash/Share0.06
Total Debt0
Total Debt/Equity0
Current Ratio26.43
Book Value Per Share1.01

Price History

52-Week Change7.69
52-Week High1
52-Week Low0.88
Moving Average 50 Days0.97
Moving Average 200 Days0.95

Statistics

Average Volume1.19M
Shares Outstanding1.12B
% Held by Institutions0.26

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield10.15
Payout Ratio0.86
Last Split FactorN/A
Last Split DateN/A
AD